Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study.
No Thumbnail Available
Authors
Gupta, Latika
Issue Date
2023-09-01
Journal
Type
Letter/Correspondence
Keywords
Idiopathic inflammatory myopathies
COVID-19
COVAD Study
Dermatomyositis
Myositis
Letter
COVID-19
COVAD Study
Dermatomyositis
Myositis
Letter
Journal Title
Rheumatology
Volume
62
Issue
9
Begin page
e263
End page
e268
Abstract
No abstract available.
Citation
Ali SS, R N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Jagtap K, Parodis I, Edgar Gracia-Ramos A, Cavagna L, Kuwana M, Knitza J, Chen YM, Makol A, Agarwal V, Patel A, Pauling JD, Wincup C, Barman B, Zamora Tehozol EA, Rojas Serrano J, La Torre IG, Colunga-Pedraza IJ, Merayo-Chalico J, Chibuzo OC, Katchamart W, Goo PA, Shumnalieva R, Hoff LS, El Kibbi L, Halabi H, Vaidya B, Shaharir SS, Hasan ATMT, Dey D, Gutiérrez CET, Caballero-Uribe CV, Lilleker JB, Salim B, Gheita T, Chatterjee T, Distler O, Saavedra MA; COVAD study group; Chinoy H, Agarwal V, Aggarwal R, Gupta L. Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study. Rheumatology (Oxford). 2023 Apr 2:kead149. doi: 10.1093/rheumatology/kead149. Epub ahead of print. PMID: 37004201.